New Zealand is the most under-discussed thing in c/insurancefights
compounding. That is the whole post, but I will justify it.
Everything else people worry about in c/tirzepatide is downstream of it. Titration speed, muscle cramps, the endless dose arguments — most of it resolves if you sort compounding out first, and almost nobody does.
I say this having got it wrong for 16 months. My hs-CRP was the thing that eventually made me pay attention, which is a stupid way to learn a lesson that was in the sidebar the whole time.
best — the order this archive was captured in
This is correct. PBS listings matter.
AU or NZ?
PBS/TGA claims need the notice or schedule entry
compounding status changed mid-2024
no naming compounders operating against current rules
Removed a chain here. The rule is one line long and it is not negotiable.
the UK here. Waited 6 months on a list, gave up, went private, and the total cost was roughly what I expected.
the UK here.
Disagree on that part. 97.9% and 97.6% on the same vial is normal.
the 2024 compounding rule change closed a major route overnight
The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
[removed by moderator]
AU and NZ are different systems, say which
- 1This is correct. PBS listings matter.6 comments in this branch · started by u/marta_ilunga
- 2the UK here. Waited 6 months on a list, gave up, went private, and the total…5 comments in this branch · started by u/devils_advocate_d